Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Graham Blackman"'
Autor:
Ebenezer Oloyede, Bethany Mantell, Julie Williams, Serena Lai, Sameer Jauhar, David Taylor, James H. MacCabe, Robert Harland, Philip McGuire, Graham Blackman
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 12 (2022)
Background: Clozapine is the only medication licenced for patients with psychosis that is resistant to conventional antipsychotic treatment. However, despite its effectiveness, it remains widely underutilised. One contributory factor for this may be
Externí odkaz:
https://doaj.org/article/3672b4c84fae4d33960b9e480d6baf3b
Autor:
Graham Blackman, Ebenezer Oloyede
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 11 (2021)
Clozapine is an atypical antipsychotic used in treatment-resistant schizophrenia. Whilst clozapine is highly effective, there are some clinical scenarios, such as the emergence of severe side effects, that necessitate its discontinuation. There is an
Externí odkaz:
https://doaj.org/article/03eb6f66cb5e4dc2a7e30b6ed1483392
Publikováno v:
Case Reports in Psychiatry, Vol 2019 (2019)
We present the case of a 25-year-old male who presented to A&E with isolated musical hallucinations, in the absence of audiological or neurological disease. The patient had a history of recreational drug use and a family history of psychosis. Halluci
Externí odkaz:
https://doaj.org/article/f4ce8574ea6c42899cdbe18bfdb69861
Autor:
Valeria Mondelli, Graham Blackman, Matthew J. Kempton, Thomas A. Pollak, Conrad Iyegbe, Lucia R. Valmaggia, Paul Amminger, Neus Barrantes-Vidal, Rodrigo Bressan, Mark van der Gaag, Lieuwe de Haan, Marie-Odile Krebs, Merete Nordentoft, Stephan Ruhrmann, Anita Riecher-Rössler, Bart P.F. Rutten, Gabriele Sachs, Nikolaos Koutsouleris, Philip McGuire
Publikováno v:
EU-GEI High Risk Study 2023, ' Serum immune markers and transition to psychosis in individuals at clinical high risk ', Brain, Behavior, and Immunity, vol. 110, pp. 290-296 . https://doi.org/10.1016/j.bbi.2023.03.014
Brain, Behavior, and Immunity, 110, 290-296. Academic Press Inc.
Brain, Behavior, and Immunity, 110, 290-296. Academic Press Inc.
Individuals at clinical high risk (CHR) for psychosis have been found to have altered cytokine levels, but whether these changes are related to clinical outcomes remains unclear. We addressed this issue by measuring serum levels of 20 immune markers
Autor:
Ebenezer Oloyede, Graham Blackman, Bethany Mantell, Eleanor Harris, Julie Williams, David Taylor, James MacCabe, Philip McGuire
Publikováno v:
Schizophrenia. 9
Clozapine is the most effective medication for treatment-resistant psychosis, but evidence points to substantial underuse, especially within early intervention psychosis (EIP) services. We explored clinicians’ views on perceived barriers and facili
Psychosis is one of the most disabling psychiatric disorders. Paediatric traumatic brain injury (pTBI) has been cited as a developmental risk factor for psychosis, however this association has never been assessed meta-analytically. A systematic revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d592f1ef4473f9875093613a3f83883
https://doi.org/10.1101/2023.02.17.23286118
https://doi.org/10.1101/2023.02.17.23286118
Autor:
Ebenezer Oloyede, Graham Blackman, Eromona Whiskey, Christian Bachmann, Olubanke Dzahini, Sukhi Shergill, David Taylor, Philip McGuire, James MacCabe
Publikováno v:
Epidemiology and psychiatric sciences. 31
Aims Clozapine is licensed for treatment-resistant psychosis and remains underutilised. This may berelated to the stringent haematological monitoring requirements that are mandatory in most countries. We aimed to compare guidelines internationally an
Publikováno v:
The Journal of neuropsychiatry and clinical neurosciences.
Fregoli syndrome is a rare delusion characterized by the belief that familiar people are presenting themselves disguised as others to the affected person. Theories of delusional misidentification have suggested secondary ("organic") underlying mechan
BackgroundVisual hallucinations are often considered by clinicians to be suggestive of a secondary cause of psychosis, however, this association has never been assessed meta-analytically. We aimed to compare the presence of visual hallucinations in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ef02c2d1f87b04b0ced72fc6d30f5f1
https://doi.org/10.1101/2022.06.07.22276049
https://doi.org/10.1101/2022.06.07.22276049
Autor:
Robert Stewart, James H. MacCabe, Alexis E. Cullen, Jonathan Rogers, Matthew M. Nour, Kira Griffiths, Jenny E. L. Lisshammar, Anthony S. David, Thomas A Pollak, Rayyan Zafar, Graham Blackman, Megan Pritchard, Philip McGuire, Ben Carter
Publikováno v:
Journal of Clinical Psychopharmacology
Background Clozapine is the only effective medication for treatment-resistant schizophrenia; however, its mechanism of action remains unclear. The present study explored whether its effectiveness is related to changes in hematological measures after